Health Condition 1: B15- Acute hepatitis A
Conditions
Interventions
Intervention1: Oâ??LIVER- T (syrup): One teaspoonful three times a day, 30 minutes after Meals up to day 84
Control Intervention1: Placebo(syrup): One teaspoonful three times a day, 30 minutes after M
Sponsors
SBL PVT LTD
Eligibility
Inclusion criteria
Inclusion criteria: • Male and female subjects18- 40 years of age • Patients having acute virus A hepatitis in the serum. • Willing to provide written informed consent along with audio video visual • Subjects willing to comply with all the study procedure and requirements
Exclusion criteria
Exclusion criteria: • Who had HBsAg in the serum • Patients who had history of ingesting hepatotoxic drugs prior to the onset of symptoms. • Women with childbearing Potential and insufficient contraception. • Female who is pregnant, planning a Pregnancy (during the course of the study) or nursing a child. • Any contraindication to blood sampling. • History of HIV Positive serology.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢Relief from clinical symptoms and changes of lab Parameters.Timepoint: â?¢Relief from clinical symptoms and changes of lab Parameters. | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢Incidence and rate of adverse eventsTimepoint: Screening to EOT (DAY 84) | — |
Countries
India
Contacts
Public ContactDr Harisha S
ICBio Clinical research Pvt Ltd
Outcome results
None listed